Neurodelta Ltd


NeuroDelta Ltd is currently a dormant company that holds intellectual property developed by Dr Nat Milton during his commercial work for NeuroDelta. The company also owns a number of websites linked to this activity, which have been redirected to this page. For commercial use of this intellectual property please email NeuroDelta Ltd directly.

NeuroDelta was a research and development group that used
in silico identification of protein-protein interactions for subsequent development as commercial models for drug and diagnostic discovery. The in silico identification techniques also aided in the design of specific peptide aptamers that recognised the specific molecular targets being studied. The concept was developed by Dr Nat Milton in 2003, won the UCL Entrepreneur's Challenge competition and led to the formation of the original NeuroDelta Ltd company. NeuroDelta Ltd was based on using this concept combined with expertise in protein-protein interactions relevant to Alzheimer's disease and led to patents being processed linked to antisense peptides as therapeutic compounds for Alzheimer's disease.


The technologies developed by NeuroDelta have been widely used in the discovery of novel peptides that have been developed as potential drugs. An example of the this work is the UK patent for the use of kissorphin peptides in the treatment of Alzheimer's disease, Creutzfeldt Jakob disease and Diabetes Mellitus that was granted to the University of Roehampton [
GB2493313 Patent]. Amongst the compounds identified by Dr Nat Milton are the antisense amyloid-ß peptides, phosphorylated amyloid-ß and the kissorphin KiSS-1 metastasis suppressor protein derived peptides. Compounds developed from these techniques include the kissorphin peptides, which inhibit amyloid-ß, amylin and prion protein fragment induced neurotoxicity in vitro, plus the R9 peptide, which inhibits catalase interactions with amyloid-ß fibrils.

Neurodelta Ltd Contact Information:

NeuroDelta Ltd
Company number: 6222473
 Registered in England & Wales

Current Neurodelta Information: NeuroDelta Ltd

Original Neurodelta Information:
Immunodelta Ltd